Background:Idiopathic granulomatous lobular mastitis (IGLM) is an uncommon non specific inflammatory disease of the breast. The IGLM is a benign condition and it confuses the surgeons with cancer owing to its clinical characteristics, experiences of diagnosis, treatment, and outcomes of one and half year follow-up of 22 patients met the required histological criteria of idiopathic granulomatous lobular mastitis were examined and evaluated. Subject and Methods:Between first November 2016 and 30 married, parous, non-smoker, and non average mean of 32.5 years (23 underwent breast ultrasonography for the clinical features following clinical examinations. The first choice of the diagnosis was the fine needle aspiration cytology (FNAC) and the false negative results were sent to the core needle No patients underwent mammography and breast magnetic resonance imaging. The patients have received steroids following accomplishment of antibiotics time period. The incision and drainage were performed for the pat one and half year to find out the response or recurrence. Results:The study showed that mass, skin thickening, and pain were the most prevalent clinical features and abscess as the sign in patients with characteristics were unilateral. Only 6 patients had given history of taking oral contraceptive. The common physical findings of clinical features and ultrasonographic finding were irregular hypoechoic mass and collection (20 cases cases). The same numbers of patients were diagnosed with FNAC and CNB. The patients received steroids therapy, underwent drainage and excision were 13, 13, and 9, respectively. Of the total patients, the lesions 31.8%. Conclusions:The patients were diagnosed with IGLM and recruited in the present study responded to different therapeutic interventions and the healing rate was 68.2%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.